Literature DB >> 8435355

Reversal of multidrug resistance in breast cancer: many more open questions than answers.

M Lehnert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435355     DOI: 10.1093/oxfordjournals.annonc.a058343

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Dexverapamil to overcome epirubicin resistance in advanced breast cancer.

Authors:  B Thürlimann; N Kröger; J Greiner; K Mross; J Schüller; E Schernhammer; K Schumacher; G Gastl; J Hartlapp; H Kupper
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 2.  Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.

Authors:  M J Kennedy; R J Jones
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 3.  Multidrug resistance in human cancer.

Authors:  M Lehnert
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.